|Day Low/High||0.29 / 0.32|
|52 Wk Low/High||0.25 / 0.58|
MedCision, LLC, the world leader in next-generation automated cell thawing for advanced therapies, and RepliCel Life Sciences, Inc.
Standard & Poor’s announced today that it has commenced Factual Stock Report coverage on RepliCel Life Sciences, Inc.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.